Home › Compare › PANRF vs MRK

PANRF vs MRK: Dividend Comparison 2026

PANRF yields 20000.00% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PANRF wins by $52481917574412746752.00M in total portfolio value
10 years
PANRF
PANRF
● Live price
20000.00%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$52481917574412746752.00M
Annual income
$51,970,745,957,167,775,000,000,000.00
Full PANRF calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — PANRF vs MRK

📍 PANRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPANRFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PANRF + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
PANRF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PANRF
Annual income on $10K today (after 15% tax)
$1,700,000.00/yr
After 10yr DRIP, annual income (after tax)
$44,175,134,063,592,610,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, PANRF beats the other by $44,175,134,063,592,610,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PANRF + MRK for your $10,000?

PANRF: 50%MRK: 50%
100% MRK50/50100% PANRF
Portfolio after 10yr
$26240958787206373376.00M
Annual income
$25,985,372,978,583,888,000,000,000.00/yr
Blended yield
99.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PANRF
No analyst data
Altman Z
-0.3
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PANRF buys
0
MRK buys
0
No recent congressional trades found for PANRF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPANRFMRK
Forward yield20000.00% ✓3.25%
Annual dividend / share$2.00$3.08 ✓
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR0%8.2% ✓
Portfolio after 10y$52481917574412746752.00M ✓$30.7K
Annual income after 10y$51,970,745,957,167,775,000,000,000.00 ✓$950.29
Total dividends collected$52448189483771600896.00M ✓$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PANRF vs MRK ($10,000, DRIP)

YearPANRF PortfolioPANRF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$2,010,700$2,000,000.00$11,192$351.54+$2.00M → PANRF
2$377,983,225$375,831,775.70$12,524$392.70+$377.97M → PANRF
3$66,433,479,469$66,029,037,418.28$14,015$438.65+$66433.47M → PANRF
4$10,916,985,471,987$10,845,901,648,955.73$15,682$489.96+$10916985.46M → PANRF
5$1,677,384,363,769,318$1,665,703,189,314,291.80$17,547$547.23+$1677384363.75M → PANRF
6$240,985,175,079,139,100$239,190,373,809,905,920.00$19,632$611.16+$240985175079.12M → PANRF
7$32,373,573,631,143,694,000$32,115,719,493,809,017,000.00$21,963$682.53+$32373573631143.68M → PANRF
8$4,066,766,648,320,630,000,000$4,032,126,924,535,306,000,000.00$24,571$762.18+$4066766648320630.00M → PANRF
9$477,730,483,406,513,300,000,000$473,379,043,092,810,300,000,000.00$27,486$851.08+$477730483406513344.00M → PANRF
10$52,481,917,574,412,750,000,000,000$51,970,745,957,167,775,000,000,000.00$30,745$950.29+$52481917574412746752.00M → PANRF

PANRF vs MRK: Complete Analysis 2026

PANRF — Stock

Panoramic Resources Limited, together with its subsidiaries, engages in the exploration, evaluation, development of mineral tenements and projects. It explores for nickel, cobalt, and copper deposits. The company holds 100% interests in the Savannah nickel project located in the East Kimberly, Western Australia. Panoramic Resources Limited was incorporated in 2001 and is headquartered in Perth, Australia.

Full PANRF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this PANRF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PANRF vs SCHDPANRF vs JEPIPANRF vs OPANRF vs KOPANRF vs MAINPANRF vs JNJPANRF vs ABBVPANRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.